Search International and National Patent Collections

1. (WO2018222652) BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

Pub. No.:    WO/2018/222652    International Application No.:    PCT/US2018/035025
Publication Date: Fri Dec 07 00:59:59 CET 2018 International Filing Date: Thu May 31 01:59:59 CEST 2018
IPC: A61Q 19/02
A61K 38/48
A61K 8/99
Applicants: ALLERGAN, INC.
Inventors: JACKY, Birgitte, P.S.
MALIK, Shizazh, Z.
WANG, Joanne
LIU, Yi
BRIDEAU-ANDERSEN, Amy
STEWARD, Lance, E.
LE, Linh, Q.
HSIA, Edward, C.
Title: BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN
Abstract:
Methods for treating hypermelanin-related afflictions of the skin, such as hyperpigmentation, are provided. The methods comprise administering a composition comprising BoNT/DC.